Cetuximab Based Chemotherapy in Recurrent and Metastatic SCC of Esophagus – A Real World Short Case Series from a Tertiary Cancer Care Center

Documenti analoghi

• Phase II Trial of Chemotherapy, Cetuximab, and Erlotinib in Patients With Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck
  di: Aarti Bhatia, et al.
  Pubblicazione: (2025)
• Histopathological Analysis of Testicular Lesions in Tertiary Care Center
  di: Dr. Parth Patel
  Pubblicazione: (2025)
• Clinical Profile And Outcomes Of Patients With Emphysematous Pyelonephritis In A Tertiary Care Center
  di: Dr Vivek Mahadeo Barekar
  Pubblicazione: (2025)
• Real World Outcomes With Chemotherapy and Immunotherapy in Metastatic Poorly Differentiated Gastroenteropancreatic Neuroendocrine Carcinomas
  di: Rushabh Gujarathi, et al.
  Pubblicazione: (2026)
• Response to Cetuximab in Squamous Cell Carcinoma of the Anal Canal After Multiple Lines of Chemotherapy and Immunotherapy
  di: Javier Mauricio Segovia
  Pubblicazione: (2024)